The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
HPV Vaccines-Global Market Insights and Sales Trends 2024
Synopsis
Human papilloma virus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available vaccines protect against either two, four, or nine types of HPV. All vaccines protect against at least HPV type 16 and 18 that cause the greatest risk of cervical cancer. It is estimated that they may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and possibly some mouth cancer. They additionally prevent some genital warts with the vaccines against 4 and 9 HPV types providing greater protection.
The global HPV Vaccines market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of HPV Vaccines in various end use industries. The expanding demands from the Male and Female, are propelling HPV Vaccines market. Adolescents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adults segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HPV Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HPV Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HPV Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HPV Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HPV Vaccines covered in this report include Astellas Pharma, CSL, Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, MedImmune, Merck, Pfizer and Sanofi Pasteur, etc.
The global HPV Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute
Global HPV Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HPV Vaccines market, Segment by Type:
Adolescents
Adults
Global HPV Vaccines market, by Application
Male
Female
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of HPV Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of HPV Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Human papilloma virus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available vaccines protect against either two, four, or nine types of HPV. All vaccines protect against at least HPV type 16 and 18 that cause the greatest risk of cervical cancer. It is estimated that they may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and possibly some mouth cancer. They additionally prevent some genital warts with the vaccines against 4 and 9 HPV types providing greater protection.
The global HPV Vaccines market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of HPV Vaccines in various end use industries. The expanding demands from the Male and Female, are propelling HPV Vaccines market. Adolescents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adults segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HPV Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HPV Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HPV Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HPV Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HPV Vaccines covered in this report include Astellas Pharma, CSL, Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, MedImmune, Merck, Pfizer and Sanofi Pasteur, etc.
The global HPV Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute
Global HPV Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HPV Vaccines market, Segment by Type:
Adolescents
Adults
Global HPV Vaccines market, by Application
Male
Female
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of HPV Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of HPV Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 HPV Vaccines Market Overview
1.1 HPV Vaccines Product Overview
1.2 HPV Vaccines Market Segment by Type
1.2.1 Adolescents
1.2.2 Adults
1.3 Global HPV Vaccines Market Size by Type
1.3.1 Global HPV Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global HPV Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global HPV Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America HPV Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe HPV Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific HPV Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America HPV Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa HPV Vaccines Sales Breakdown by Type (2018-2023)
2 Global HPV Vaccines Market Competition by Company
2.1 Global Top Players by HPV Vaccines Sales (2018-2023)
2.2 Global Top Players by HPV Vaccines Revenue (2018-2023)
2.3 Global Top Players by HPV Vaccines Price (2018-2023)
2.4 Global Top Manufacturers HPV Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 HPV Vaccines Market Competitive Situation and Trends
2.5.1 HPV Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by HPV Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HPV Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into HPV Vaccines Market
2.8 Key Manufacturers HPV Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 HPV Vaccines Status and Outlook by Region
3.1 Global HPV Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global HPV Vaccines Historic Market Size by Region
3.2.1 Global HPV Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global HPV Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global HPV Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global HPV Vaccines Forecasted Market Size by Region
3.3.1 Global HPV Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global HPV Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global HPV Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global HPV Vaccines by Application
4.1 HPV Vaccines Market Segment by Application
4.1.1 Male
4.1.2 Female
4.2 Global HPV Vaccines Market Size by Application
4.2.1 Global HPV Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global HPV Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global HPV Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America HPV Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe HPV Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific HPV Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America HPV Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa HPV Vaccines Sales Breakdown by Application (2018-2023)
5 North America HPV Vaccines by Country
5.1 North America HPV Vaccines Historic Market Size by Country
5.1.1 North America HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America HPV Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America HPV Vaccines Sales in Value by Country (2018-2023)
5.2 North America HPV Vaccines Forecasted Market Size by Country
5.2.1 North America HPV Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America HPV Vaccines Sales in Value by Country (2024-2029)
6 Europe HPV Vaccines by Country
6.1 Europe HPV Vaccines Historic Market Size by Country
6.1.1 Europe HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe HPV Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe HPV Vaccines Sales in Value by Country (2018-2023)
6.2 Europe HPV Vaccines Forecasted Market Size by Country
6.2.1 Europe HPV Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe HPV Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific HPV Vaccines by Region
7.1 Asia-Pacific HPV Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific HPV Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific HPV Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific HPV Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific HPV Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific HPV Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific HPV Vaccines Sales in Value by Region (2024-2029)
8 Latin America HPV Vaccines by Country
8.1 Latin America HPV Vaccines Historic Market Size by Country
8.1.1 Latin America HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America HPV Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America HPV Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America HPV Vaccines Forecasted Market Size by Country
8.2.1 Latin America HPV Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America HPV Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa HPV Vaccines by Country
9.1 Middle East and Africa HPV Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa HPV Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa HPV Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa HPV Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa HPV Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa HPV Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Astellas Pharma
10.1.1 Astellas Pharma Company Information
10.1.2 Astellas Pharma Introduction and Business Overview
10.1.3 Astellas Pharma HPV Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Astellas Pharma HPV Vaccines Products Offered
10.1.5 Astellas Pharma Recent Development
10.2 CSL
10.2.1 CSL Company Information
10.2.2 CSL Introduction and Business Overview
10.2.3 CSL HPV Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CSL HPV Vaccines Products Offered
10.2.5 CSL Recent Development
10.3 Emergent BioSolutions
10.3.1 Emergent BioSolutions Company Information
10.3.2 Emergent BioSolutions Introduction and Business Overview
10.3.3 Emergent BioSolutions HPV Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Emergent BioSolutions HPV Vaccines Products Offered
10.3.5 Emergent BioSolutions Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Information
10.4.2 GlaxoSmithKline Introduction and Business Overview
10.4.3 GlaxoSmithKline HPV Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 GlaxoSmithKline HPV Vaccines Products Offered
10.4.5 GlaxoSmithKline Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Information
10.5.2 Johnson & Johnson Introduction and Business Overview
10.5.3 Johnson & Johnson HPV Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Johnson & Johnson HPV Vaccines Products Offered
10.5.5 Johnson & Johnson Recent Development
10.6 MedImmune
10.6.1 MedImmune Company Information
10.6.2 MedImmune Introduction and Business Overview
10.6.3 MedImmune HPV Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 MedImmune HPV Vaccines Products Offered
10.6.5 MedImmune Recent Development
10.7 Merck
10.7.1 Merck Company Information
10.7.2 Merck Introduction and Business Overview
10.7.3 Merck HPV Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Merck HPV Vaccines Products Offered
10.7.5 Merck Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer HPV Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer HPV Vaccines Products Offered
10.8.5 Pfizer Recent Development
10.9 Sanofi Pasteur
10.9.1 Sanofi Pasteur Company Information
10.9.2 Sanofi Pasteur Introduction and Business Overview
10.9.3 Sanofi Pasteur HPV Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sanofi Pasteur HPV Vaccines Products Offered
10.9.5 Sanofi Pasteur Recent Development
10.10 Serum Institute
10.10.1 Serum Institute Company Information
10.10.2 Serum Institute Introduction and Business Overview
10.10.3 Serum Institute HPV Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Serum Institute HPV Vaccines Products Offered
10.10.5 Serum Institute Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 HPV Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 HPV Vaccines Industrial Chain Analysis
11.4 HPV Vaccines Market Dynamics
11.4.1 HPV Vaccines Industry Trends
11.4.2 HPV Vaccines Market Drivers
11.4.3 HPV Vaccines Market Challenges
11.4.4 HPV Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 HPV Vaccines Distributors
12.3 HPV Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
